Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | — |
62-year-old received Bexsero; This non-serious case was reported by a consumer via patient support programs and described the occurrence of inappropriate age at vaccine administration in a 62-year-old male patient who received Men B NVS (Bexsero) for prophylaxis. The patient's past medical history included splenectomy. On 24-MAR-2025, the patient received Bexsero .5 ml. On 24-MAR-2025, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: 62-year-old received Bexsero). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 30-JUL-2025 Reporter requested billing and coding assistance and provided the indication of splenectomy as the reason the vaccine was administered. The report was not for an adverse event. 62-year-old received Bexsero which led to inappropriate age at vaccine administration.
Medical History/Concurrent Conditions: Splenectomy